Ad Code

For Advertisement contact AP UPDATES 7386670681

Bharat Biotech’s nasal booster gets nod for trials

AP UPDATES January 29, 2022
Bharat Biotech has received the Drugs Controller General of India (DCGI)’s permission for conducting Phase-III clinical trials of its intranasal Covid-19 vaccine BBV154 as a booster for other vaccines.

Post a Comment

0 Comments

Emoji
(y)
:)
:(
hihi
:-)
:D
=D
:-d
;(
;-(
@-)
:P
:o
:>)
(o)
:p
(p)
:-s
(m)
8-)
:-t
:-b
b-(
:-#
=p~
x-)
(k)
Close Menu